LESLIE ARCHER: Open Payments
NPI 1033194436 · VALENCIA, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,667 in 86 payments from 14 companies in 2025. Trend: 2023 $2,429 · 2024 $1,886 · 2025 $1,667
Food & beverage: $1,667
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 18 | $342 |
| GlaxoSmithKline, LLC. | 14 | $276 |
| ABBVIE INC. | 9 | $236 |
| Daiichi Sankyo Inc. | 9 | $195 |
| Lilly USA, LLC | 9 | $180 |
| Amgen Inc. | 12 | $156 |
| Exact Sciences Corporation | 4 | $68 |
| AstraZeneca Pharmaceuticals LP | 4 | $67 |
| PFIZER INC. | 2 | $40 |
| Axsome Therapeutics, Inc. | 1 | $23 |
Products named: TRELEGY ELLIPTA, INJECTAFER, MOUNJARO, QULIPTA, Wegovy, OTEZLA, UBRELVY, The Cologuard Plus Collection Kit.
Industry payments across PA — which companies pay providers there.
